Physician profile
Stephen E Lockwood
NPI 1184837932
$636.27
in general payments reported to CMS, 2019-2025
13 companies · $41.09 in 2025
The $41.09 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $16.16 · 2021: $92.71 · 2022: $63.83 · 2023: $185 · 2024: $124 · 2025: $41.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309 · Entertainment: $41.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.91 |
| Entertainment | $41.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $223.11 | 2019-2024 | |
| Biohorizons Implant Systems INC. | $79.42 | 2021-2023 | Biohorizons |
| Orapharma, A Division of Bausch Health US, LLC | $62.79 | 2019-2020 | |
| 3m Company | $55.75 | 2019-2023 | 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, Scotchbond Universal Plus |
| Implant Direct Sybron International LLC | $45.72 | 2021-2022 | |
| Keystone Dental INC. | $41.09 | 2025 | |
| Salvin Dental Specialties, INC. | $26.85 | 2019 | |
| Dentsply Sirona INC | $24.94 | 2021 | |
| Solventum Corporation | $20.02 | 2024 | Clinpro 5000, 3m Filtek |
| Patterson Companies, INC. | $18.90 | 2023 | |
| Colgate Oral Pharmaceuticals, INC. | $13.80 | 2024 | |
| Peter Brasseler Holdings, LLC | $12.77 | 2019 | |
| Ultradent Products INC | $11.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lockwood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.